Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Gammagard

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



I have Alzheimer Disease

hormone replacement therapy1 - prevention of delirium1 - perusini1 - dementia decline1 - reconceptualization1 - apoe-e4 gene1 - coronary heart disease1 - abnormal tau protein1 - developing dementia2 - pocd1 - vascular dementia warning signs1 - sign of alzheimer's1 - transient ischaemic attack1 - beta-blocker drugs1 - drug addiction1 - amyloid markers1 - effective aging1 - donepezil3 - senile atrophy and aphasia1 - cholinesterase inhibitors1 - aortic valve stenosis2 - alzheimer's proteins1 - postoperative cognitive dysfunction1 - downs syndrome1 - trouble sleeping1 - parkinson's diseases1 - alcohol-related brain damage1 - reducing anxiety1 - apraxia3 - mixed forms1 -